Toggle Side Panel
News + Resources
Downloads & Resources
Market Trends and Category Guides
CDMO News
Biotech Profiles
Podcast
Directory
Events
CDMO Live
ExM Leaders
More options
Sign in
Sign up
Search for:
News + Resources
Podcast
Downloads & Resources
CDMO News
Biotech Profiles
Directory
Events
Search for:
Close search
Biotech News
The latest biotechnology news and insights
Sign up to our newsletter
Newleos Therapeutics Appoints Timothy Noyes as President and CEO
Aarvik Therapeutics Welcomes Laurus Labs as Strategic Investor
Leyden Labs Raises €30M from EIC Fund and Invest-NL for Respiratory Virus Pipeline
Glox Therapeutics Receives Share of £3M CF AMR Syndicate Fund to Combat Lung Infections
Afrigen Biologics Secures $6.2 Million Grant to Develop mRNA Vaccine for Rift Valley Fever
InnoCare Pharma and KeyMed Partner with Prolium Bioscience for Exclusive License Agreement
Micron Biomedical Secures $16M, Boosting Series A to $33M
Be Bio Secures $92M Series C Funding to Advance BCM Therapies
Granata Bio Secures $15M Series A+ to Advance Reproductive Health Innovation
Tune Therapeutics Secures $175M Financing to Accelerate Epigenome Editing Pipeline
Immunis, Inc. Raises $25 Million to Advance IMM01-STEM in Elderly Patients
Ouro Medicines Launches with $120M Funding to Advance Immune Reset Therapies
Windward Bio Launches with $200M Backing to Advance WIN378 for Severe Asthma
A2 Biotherapeutics Secures $80M Series C to Advance Logic-Gated CAR-T Therapies
Timberlyne Therapeutics Secures $180M Series A to Best-in-Class Anti-CD38 Monoclonal Antibody
Leyden Labs Raises $70M to Advance Mucosal Protection Platform
Alesta Therapeutics Secures €65M Series A to Advance Rare Disease Treatments
« Previous
Page
1
Page
2
Page
3
Page
4
Next »
Glox Therapeutics Receives Share of £3M CF AMR Syndicate Fund to Combat Lung Infections
Afrigen Biologics Secures $6.2 Million Grant to Develop mRNA Vaccine for Rift Valley Fever
InnoCare Pharma and KeyMed Partner with Prolium Bioscience for Exclusive License Agreement
Micron Biomedical Secures $16M, Boosting Series A to $33M
Be Bio Secures $92M Series C Funding to Advance BCM Therapies
Granata Bio Secures $15M Series A+ to Advance Reproductive Health Innovation
Tune Therapeutics Secures $175M Financing to Accelerate Epigenome Editing Pipeline
Immunis, Inc. Raises $25 Million to Advance IMM01-STEM in Elderly Patients
Ouro Medicines Launches with $120M Funding to Advance Immune Reset Therapies
Windward Bio Launches with $200M Backing to Advance WIN378 for Severe Asthma
A2 Biotherapeutics Secures $80M Series C to Advance Logic-Gated CAR-T Therapies
Timberlyne Therapeutics Secures $180M Series A to Best-in-Class Anti-CD38 Monoclonal Antibody
Leyden Labs Raises $70M to Advance Mucosal Protection Platform
Alesta Therapeutics Secures €65M Series A to Advance Rare Disease Treatments
« Previous
Page
1
Page
2
Page
3
Page
4
Next »
European CDMO Landscape 2025:
Download the latest edition